Search Results - "De Smedt, Renate"
-
1
Direct and indirect anti-leukemic properties of activity-on-target interferons for the treatment of T-cell acute lymphoblastic leukemia
Published in Haematologica (Roma) (01-06-2022)Get full text
Journal Article -
2
Targeting hyperactive platelet-derived growth factor receptor-β signaling in T-cell acute lymphoblastic leukemia and lymphoma
Published in Haematologica (Roma) (01-05-2024)“…T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) are rare aggressive hematologic malignancies. Current treatment consists…”
Get full text
Journal Article -
3
Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma
Published in Haematologica (Roma) (01-01-2019)Get full text
Journal Article -
4
Targeting steroid resistance in T-cell acute lymphoblastic leukemia
Published in Blood reviews (01-11-2019)“…T-cell acute lymphoblastic leukemia (T-ALL) is characterized by a variable response to steroids during induction and/or consolidation therapy. Notably, recent…”
Get full text
Journal Article -
5
PDGFR-β As a New Therapeutic Target in T-Cell Acute Lymphoblastic Leukemia
Published in Blood (15-11-2022)Get full text
Journal Article -
6
3066 – TARGETING HYPERACTIVE PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA IN T CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND T CELL LYMPHOBLASTIC LYMPHOMA
Published in Experimental hematology (2022)“…Platelet derived growth factor β (PDGFR-β) is a transmembrane glycoprotein dimer molecule that functions as a receptor tyrosine kinase. Ligand binding results…”
Get full text
Journal Article -
7
Targeting cytokine- and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphoma
Published in Blood (07-05-2020)“…T-cell acute lymphoblastic leukemia (T-ALL) and T-cell acute lymphoblastic lymphoma (T-LBL) are aggressive hematological malignancies that are currently…”
Get full text
Journal Article -
8
Genetic Activation and Therapeutic Targeting of PIM1 in T-Cell Acute Lymphoblastic Leukemia/Lymphoma
Published in Blood (08-12-2017)“…T-cell acute lymphoblastic leukemia (T-ALL) and T-cell acute lymphoblastic lymphoma (T-LBL) are aggressive immature T-cell malignancies that are often…”
Get full text
Journal Article -
9
Pre-Clinical Evaluation of the Hypomethylating Agent Decitabine for the Treatment of T-Cell Lymphoblastic Lymphoma
Published in Cancers (20-01-2023)“…T-cell lymphoblastic lymphoma (T-LBL) is a rare and aggressive lymphatic cancer, often diagnosed at a young age. Patients are treated with intensive…”
Get full text
Journal Article